Ferreira Juan Camilo Arjona insider trades: Myovant Sciences (MYOV) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ferreira reports to the SEC
Open-market buys and sales
35 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 18, 2023 | MYOV | ↓ Sell | 1,109 | $26.89 | $30K | Direct | Jan 20, 2023 (2d) |
| Jan 4, 2023 | MYOV | ↓ Sell | 2,251 | $26.90 | $61K | Direct | Jan 5, 2023 (1d) |
| Oct 18, 2022 | MYOV | ↓ Sell | 1,604 | $25.20 | $40K | Direct | Oct 20, 2022 (2d) |
| Oct 4, 2022 | MYOV | ↓ Sell | 2,738 | $24.40 | $67K | Direct | Oct 6, 2022 (2d) |
| Jul 18, 2022 | MYOV | ↓ Sell | 1,606 | $12.87 | $21K | Direct | Jul 20, 2022 (2d) |
| Jul 6, 2022 | MYOV | ↓ Sell | 2,755 | $13.40 | $37K | Direct | Jul 8, 2022 (2d) |
| May 27, 2022 | MYOV | ↓ Sell | 1,382 | $10.07 | $14K | Direct | Jun 1, 2022 (5d) |
| Apr 19, 2022 | MYOV | ↓ Sell | 4,632 | $10.45 | $48K | Direct | Apr 21, 2022 (2d) |
| Apr 5, 2022 | MYOV | ↓ Sell | 1,922 | $13.78 | $26K | Direct | Apr 7, 2022 (2d) |
| Mar 1, 2022 | MYOV | ↓ Sell | 1,362 | $13.35 | $18K | Direct | Mar 3, 2022 (2d) |
| Jan 4, 2022 | MYOV | ↓ Sell | 2,271 | $16.27 | $37K | Direct | Jan 6, 2022 (2d) |
| Nov 29, 2021 | MYOV | ↓ Sell | 1,978 | $19.30 | $38K | Direct | Dec 1, 2021 (2d) |
| Nov 4, 2021 | MYOV | ↓ Sell10b5-1 | 3,800 | $24.02 | $91K | Direct | Nov 5, 2021 (1d) |
| Oct 5, 2021 | MYOV | ↓ Sell | 2,738 | $21.62 | $59K | Direct | Oct 7, 2021 (2d) |
| Sep 27, 2021 | MYOV | ↓ Sell10b5-1 | 7,000 | $24.32 | $170K | Direct | Sep 29, 2021 (2d) |
| Aug 30, 2021 | MYOV | ↓ Sell10b5-1 | 22,978 | $23.93 | $550K | Direct | Aug 31, 2021 (1d) |
| Jul 7, 2021 | MYOV | ↓ Sell | 2,777 | $21.75 | $60K | Direct | Jul 9, 2021 (2d) |
| May 28, 2021 | MYOV | ↓ Sell10b5-1 | 3,083 | $24.00 | $74K | Direct | Jun 2, 2021 (5d) |
| May 26, 2021 | MYOV | ↓ Sell10b5-1 | 12,700 | $24.23 | $308K | Direct | May 28, 2021 (2d) |
| Apr 6, 2021 | MYOV | ↓ Sell | 8,114 | $18.63 | $151K | Direct | Apr 8, 2021 (2d) |
| Mar 19, 2021 | MYOV | ↓ Sell10b5-1 | 7,000 | $24.17 | $169K | Direct | Mar 23, 2021 (4d) |
| Mar 1, 2021 | MYOV | ↓ Sell | 1,513 | $22.55 | $34K | Direct | Mar 3, 2021 (2d) |
| Dec 18, 2020 | MYOV | ↓ Sell10b5-1 | 2,000 | $26.00 | $52K | Direct | Dec 22, 2020 (4d) |
| Dec 15, 2020 | MYOV | ↓ Sell10b5-1 | 7,000 | $23.92 | $167K | Direct | Dec 17, 2020 (2d) |
| Dec 10, 2020 | MYOV | ↓ Sell10b5-1 | 10,000 | $26.04 | $260K | Direct | Dec 14, 2020 (4d) |
| Nov 30, 2020 | MYOV | ↓ Sell | 1,978 | $23.65 | $47K | Direct | Dec 2, 2020 (2d) |
| Nov 17, 2020 | MYOV | ↓ Sell10b5-1 | 7,000 | $20.00 | $140K | Direct | Nov 19, 2020 (2d) |
| Nov 13, 2020 | MYOV | ↓ Sell10b5-1 | 7,000 | $20.00 | $140K | Direct | Nov 17, 2020 (4d) |
| Sep 15, 2020 | MYOV | ↓ Sell10b5-1 | 7,000 | $21.77 | $152K | Direct | Sep 17, 2020 (2d) |
| Aug 31, 2020 | MYOV | ↓ Sell10b5-1 | 11,307 | $20.00 | $226K | Direct | Sep 2, 2020 (2d) |
| Aug 28, 2020 | MYOV | ↓ Sell10b5-1 | 9,147 | $19.07 | $174K | Direct | Aug 31, 2020 (3d) |
| Aug 19, 2020 | MYOV | ↓ Sell10b5-1 | 635 | $20.00 | $13K | Direct | Aug 21, 2020 (2d) |
| Jun 24, 2020 | MYOV | ↓ Sell10b5-1 | 17,446 | $20.00 | $349K | Direct | Jun 26, 2020 (2d) |
| Jun 23, 2020 | MYOV | ↓ Sell10b5-1 | 4,054 | $20.00 | $81K | Direct | Jun 24, 2020 (1d) |
| Feb 15, 2019 | MYOV | ↓ Sell | 260 | $21.15 | $5K | Direct | Feb 20, 2019 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Ferreira Juan Camilo Arjona's insider trades
Ferreira Juan Camilo Arjona is Chief Medical Officer at Myovant Sciences (MYOV). Since Feb 15, 2019, Ferreira has reported no open-market purchases and 35 sales worth $3.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
17 sales (80% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (24 filings), grants and awards (10 filings), shares withheld for taxes (7 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MYOV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.